RNA

CAMP4 is latest biotech to eye IPO, while Upstream spells out $182M plans
Fierce Biotech
Mon, 10/7/24 - 09:58 pm
CAMP4 Therapeutics
IPOs
Upstream Bio
RNA
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney
BioPharma Dive
Mon, 10/7/24 - 11:18 am
Jude Bio
RNA
ligand-siRNA
funding
Eli Lilly unwraps $700M nucleic acid R&D center in Boston Seaport, opens doors to biotechs
Fierce Biotech
Tue, 08/13/24 - 11:49 am
Eli Lilly
Boston
R&D
DNA
RNA
Triastek and BioNTech to develop 3D-printed RNA therapeutics
Pharmaceutical Technology
Wed, 07/24/24 - 11:00 pm
BioNTech
Triastek
3D printing
RNA
Early data for Avidity's RNA therapy show possible functional benefit in muscular dystrophy
Fierce Biotech
Wed, 06/12/24 - 11:19 pm
Avidity Biosciences
RNA
AOC 1020
del-brax
FSHD
clinical trials
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive
Mon, 06/3/24 - 11:55 am
Eli Lilly
ALS
QurAlis
RNA
RNA blood test may predict antidepressant response
Pharmaphorum
Wed, 05/8/24 - 11:09 am
Circular Genomics
RNA
circRNA
biomarkers
antidepressants
Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on oligonucleotides?
Biopharma Reporter
Tue, 04/30/24 - 11:18 am
RNA
biotech
Asia-Pacific
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Fierce Biotech
Mon, 04/22/24 - 11:44 am
Boehringer Ingelheim
Ochre Bio
RNA
MASH
NASH
Two more pharmas practice their Accent, invest in $75M series C round
Fierce Biotech
Tue, 01/23/24 - 10:47 am
Accent Therapeutics
funding
RNA
Bristol Myers Squibb
JNJ
AbbVie
A new delivery method muscling its way into the RNA space
Pharma Voice
Thu, 11/9/23 - 09:41 am
Avidity Biosciences
RNA
drug delivery
FDA denies expanded approval for Alnylam RNA drug
BioPharma Dive
Mon, 10/9/23 - 10:15 am
Alnylam
FDA
RNA
Patisiran
ATTR amyloidosis
Roche pays Ionis $60M upfront to license RNA-targeting Alzheimer's, Huntington's programs
Fierce Biotech
Wed, 09/27/23 - 10:14 am
Roche
Ionis Pharmaceuticals
RNA
Alzheimer's disease
Huntington's disease
Pfizer hooks up with Ginkgo for $331M biobucks deal on unspecified targets
Fierce Biotech
Wed, 09/27/23 - 10:07 am
Ginkgo Bioworks
Pfizer
drug discovery
RNA
Alltrna raises $109M for ‘transfer RNA’ drug vision
BioPharma Dive
Wed, 08/9/23 - 10:45 pm
Alltrna
RNA
transfer RNA
Flagship Pioneering
tRNA
Amber Bio Raises $26 Million Seed Financing to Advance New RNA-Based Gene Editing Platform
Yahoo/Businesswire
Thu, 08/3/23 - 10:15 am
Amber Bio
funding
gene editing
RNA
Novo Nordisk turns RNAi research up to Eleven with new biotech pact
Fierce Biotech
Mon, 07/17/23 - 08:53 am
Novo Nordisk
RNA
Eleven Biotherapeutics
Charles River Laboratories, Curigin partner on gene therapy
Pharmaceutical Business Review
Tue, 06/13/23 - 10:41 am
Charles River Laboratories
Curigin
gene therapy
RNA
After layoffs leave Oncorus a 'shell' of a company, board liquidates the business
Fierce Biotech
Mon, 06/12/23 - 09:52 am
Oncorus
bankruptcy
RNA
Facing bankruptcy, RNA-focused Oncorus lays off 'substantially' all its staff
Fierce Biotech
Fri, 06/2/23 - 10:09 am
Oncorus
layoffs
RNA

Pages